Member Directory

Sun Pharma Agrees to Pay $485 Million to Resolve Antitrust Cases

Sun Pharmaceutical Industries Ltd on Wednesday said it had agreed to pay $485 million to resolve class action lawsuits alleging the Indian drugmaker's subsidiary Ranbaxy engaged in an anticompetitive scheme to delay the launch of generic drugs by rivals.

The settlement came ahead of an April 5 trial in Boston federal court over claims by generic drug buyers who said they were owed billions of dollars for being overcharged as a result of a fraud Ranbaxy Laboratories perpetrated on U.S. regulators.

Read the source article at reuters.com

Contact Us Today

Read More Legal News

The National Trial Lawyers White Logo for Footer
© Copyright 2022, All Rights Reserved | National Trial Lawyers
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram